According to the statistics of dolphin stock data, as of the closing, the stock price of Yixintang was 30.55 yuan, with a rise and fall of 3.63%, a turnover rate of 2.26%, and a transaction of 217 million yuan throughout the day.
01. Real-time funds
Today, the stock's main funds flowed in 59.29 million yuan, outflow of 54.34 million yuan, and net inflow of 4.9501 million yuan, of which the net inflow of 6.7572 million yuan, the net outflow of large orders was 1.807 million yuan, the net outflow of medium orders was 6.2202 million yuan, and the net outflow of small orders was 1.524 million yuan.
02. Industry ranking
The industry to which this stock belongs is the medical industry industry. A total of 97 companies in the industry rose, 20 companies fell, and the leading stock was Baolet , with an increase of +10.01%. Judging from the ranking of the main net inflows in the sector, Yixintang today ranked 45th in the industry. Today, the main capital in the medical industry flowed in 17.326 billion yuan, outflowed outflows of 15.532 billion yuan, and the net inflow was 1.794 billion yuan, with an overall increase and decline of +2.23%.
| ranking | name | rise and fall | main inflow | main outflow | main inflow | main inflow | main inflow | main inflow | transaction amount |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Yuyue Medical | +7.22% | 114 billion | 84 billion | 84 billion | 0 billion | 84 billion 12 | .30 billion | 2.34 billion |
| 2 | 1 Wantai Biological | +10.00% | .815 billion | .646 billion | .168 billion | .1338 billion | |||
| 3 | 3 | WuXi AppTec | + 2.33% | .896 billion | .734 billion | .162 billion | 1.479 billion | ||
| 4 | 4 | Mindray Medical | +1.91% | 1281 billion | 1.141 billion | .140 billion | 2.038 billion | ||
| 5 | BGI | +2.63% | 761 billion | 647 billion | 1114 billion | 1338 billion |
03. Funding trend
Yixintang cumulative rise and fall in the past 20 days was 10.73%, and the main force cumulative net inflow was 111 million yuan during the period. As of today's closing, the total market value of Yixintang is 17.502 billion yuan.
| Time period | cumulative rise and fall | main cumulative net inflow | cumulative transaction amount | |
|---|---|---|---|---|
| 3 days | 3.04% | 17733 million | 5.58 billion | |
| 5 days | 3.04% | 2026.01 million | 777 billion | 777 billion |
| 5 days | 3.04% | 2026.01 million | 777 billion | 777 billion |
| 5 days | 3.04% | 2026.01 million | 777 billion | 777 billion |
| 5 days | 3.04% | 2026.01 million | 777 billion | b12b11770 million b12b12b12b11770 million b12b12b12b12b12b11770 million b12b12b12b12b12b12b11770 million b12b12b12b12b12b1177 10|
| 10 | -1.13% | 654457 million | 1645 billion | |
| 20 | 10.73% | 111 billion | 3948 billion |
04. Texture analysis
Company's main business: The company's main business is pharmaceutical retail chain and pharmaceutical wholesale business, among which pharmaceutical retail chain is the company's core business. .
As of March 31, 2020, Yixintang 's operating income was 3.087 billion yuan, and the net profit attributable to the parent company's shareholders was 205 million yuan, an increase of 16.81% year-on-year.
In the past three months, 275 institutions conducted research on Yixintang , and the stock has received high attention from institutions.
Click to download the Dolphin Stock APP, and the smart market-oriented free experience for life
Disclaimer: The information provided on this page is for investors' reference only and does not constitute any investment advice.
